Partner, Venture Investments
Clinical trial shows effectiveness of AI-driven app Sweetch is a start-up with a mobile health app that aims to use AI to help users prevent diabetes — or improve outcomes for users who have diabetes. The app personalizes recommendations for each user, offering them the tailored support and encouragement they need to make long-term behavior changes. In 2016, Sweetch raised $3.5 million, led by global conglomerate Philips and equity crowdfunding platform OurCrowd. A clinical trial conducted at Johns Hopkins University found that Sweetch was highly effective at modifying participant behavior. On average, participants lost weight, reduced their waist circumference and had a clinically meaningful reduction in their A1C levels.
You are about to visit a Philips global content page
ContinueThe information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.